NCT05091645 Translation and Cultural Adaptation of the Groningen Frailty Indicator (GFI) in Patients With Hip Fracture
| NCT ID | NCT05091645 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Thessaly |
| Condition | Frailty Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 89 participants |
| Start Date | 2022-02-25 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 89 participants in total. It began in 2022-02-25 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study attempts to the translation and the cultural adaptation of the Groningen Frailty Indicator (GFI) questionnaire in the Greek population in patients suffering from hip fracture.
Eligibility Criteria
Inclusion Criteria: * adult patients over 65 years old with hip fractures undergoing surgery * an ASA (American Society of Anesthesiologists) PS (physical status) I to III * non-institutionalized * able to communicate orally or in writing * consent to participate Exclusion Criteria: * refused to participate * pathological hip fractures * institutionalized * patients with hip fracture treated conservatively * patients with severe cognitive dysfunction * patients with insufficient knowledge of the Greek language
Contact & Investigator
Eleni Arnaoutoglou, MD, PhD
PRINCIPAL INVESTIGATOR
University of Thessaly
Frequently Asked Questions
Who can join the NCT05091645 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Frailty Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05091645 currently recruiting?
Yes, NCT05091645 is actively recruiting participants. Contact the research team at earnaout@gmail.com for enrollment information.
Where is the NCT05091645 trial being conducted?
This trial is being conducted at Larissa, Greece.
Who is sponsoring the NCT05091645 clinical trial?
NCT05091645 is sponsored by University of Thessaly. The principal investigator is Eleni Arnaoutoglou, MD, PhD at University of Thessaly. The trial plans to enroll 89 participants.